Oregon Public Employees Retirement Fund bought a new stake in shares of Medidata Solutions, Inc. (NASDAQ:MDSO) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,827 shares of the company’s stock, valued at approximately $925,000.

Other hedge funds also recently modified their holdings of the company. Global Thematic Partners LLC boosted its stake in shares of Medidata Solutions by 36.5% in the first quarter. Global Thematic Partners LLC now owns 871,049 shares of the company’s stock valued at $50,251,000 after buying an additional 232,810 shares during the last quarter. Nationwide Fund Advisors boosted its stake in shares of Medidata Solutions by 41.5% in the first quarter. Nationwide Fund Advisors now owns 635,314 shares of the company’s stock valued at $36,651,000 after buying an additional 186,356 shares during the last quarter. Diversified Trust Co boosted its stake in shares of Medidata Solutions by 10.3% in the first quarter. Diversified Trust Co now owns 5,350 shares of the company’s stock valued at $309,000 after buying an additional 500 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in shares of Medidata Solutions by 2.2% in the first quarter. State of Alaska Department of Revenue now owns 6,080 shares of the company’s stock valued at $350,000 after buying an additional 130 shares during the last quarter. Finally, Everence Capital Management Inc. bought a new stake in shares of Medidata Solutions during the first quarter valued at about $214,000.

Medidata Solutions, Inc. (MDSO) traded up 0.52% during trading on Friday, hitting $77.71. The stock had a trading volume of 225,110 shares. The firm has a market cap of $4.40 billion, a price-to-earnings ratio of 125.54 and a beta of 1.79. The stock’s 50-day moving average is $77.80 and its 200 day moving average is $65.11. Medidata Solutions, Inc. has a one year low of $46.10 and a one year high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, beating the Zacks’ consensus estimate of $0.28 by $0.03. The business had revenue of $137.41 million during the quarter, compared to the consensus estimate of $134.28 million. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.24 earnings per share. Equities analysts anticipate that Medidata Solutions, Inc. will post $1.28 earnings per share for the current year.

WARNING: “11,827 Shares in Medidata Solutions, Inc. (MDSO) Acquired by Oregon Public Employees Retirement Fund” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/05/11827-shares-in-medidata-solutions-inc-mdso-acquired-by-oregon-public-employees-retirement-fund.html.

Several analysts have issued reports on the company. J P Morgan Chase & Co upped their target price on Medidata Solutions to $87.00 and gave the company an “overweight” rating in a report on Tuesday, July 18th. Citigroup Inc. restated a “buy” rating and issued a $94.00 target price (up from $77.00) on shares of Medidata Solutions in a report on Monday, July 10th. Piper Jaffray Companies upped their target price on Medidata Solutions to $87.00 and gave the company an “overweight” rating in a report on Friday, July 7th. SunTrust Banks, Inc. upped their target price on Medidata Solutions from $80.00 to $90.00 and gave the company a “buy” rating in a report on Tuesday, June 27th. Finally, BidaskClub cut Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $78.17.

In other news, Director Robert Taylor sold 5,639 shares of Medidata Solutions stock in a transaction on Monday, June 5th. The stock was sold at an average price of $73.46, for a total value of $414,240.94. Following the completion of the sale, the director now owns 54,372 shares of the company’s stock, valued at $3,994,167.12. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Michael L. Capone sold 5,000 shares of Medidata Solutions stock in a transaction on Monday, May 15th. The shares were sold at an average price of $69.46, for a total value of $347,300.00. Following the completion of the sale, the chief operating officer now directly owns 171,754 shares of the company’s stock, valued at approximately $11,930,032.84. The disclosure for this sale can be found here. 5.80% of the stock is owned by insiders.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.